- Contact Us
- News and Events
- Investor Relations
- Locations and Facilities
- Careers
- About Our Site
- Accessibility Statement
- Privacy Policy
- Terms and Conditions
- For Employers and Medical Plan Providers
- For Pharmacists and Medical Professionals
- Drug Lists
- Drug Safety Alerts
- Emergency Response
- Mail Service Numbers, Forms and Information
- Specialty Pharmacy Services, Information and Forms
- Electronic Prior Authorization Information
- Clinical Drug Information
- Clinical Programs and Health Management
- Clinical Publications
- FAQs For Pharmacists and Pharmacy Staff
- Pharmacy Help Desk
- FAQs For Prescribers and Office Staff
- Contact Us | Health Professionals Only
Drug Safety Alerts
Gamunex®-C 10% Consumer Level Withdrawal
12/16/2019
On December 16, 2019, Grifols Therapeutics issued a consumer-level withdrawal of Gamunex®-C 10% NDC # 13533-0800-71.This withdrawal is being conducted due to a higher rate of allergic/hypersensitivity reactions, a smaller number of which were considered medically significant. Hypersensitivity and anaphylactic/anaphylactoid reactions are a known risk with IVIG products. Patients using the affected withdrawn product have been advised to discontinue the product and call their providers immediately.
This withdrawal affects lot number A4GKD00232 exp. 06/08/22. No other lots are affected by this withdrawal. The affected lot went into distribution on July 29, 2019.
CVS Caremark® Response:
Please note: This product is not carried by the CVS Caremark® Mail Service Pharmacies.
For more information about this withdrawal, please contact Grifols Therapeuticsat 1-800-520-2807 or visit www.grifols.com. You may also contact the U.S. Food and Drug Administration (FDA) consumer inquiry line at 1-888-INFO-FDA (1-888-463-6332) or visit www.fda.gov.